Synthetic immune niches for cancer immunotherapy

Nature Reviews Immunology 18, 212 (2018). doi:10.1038/nri.2017.89 Authors: Jorieke Weiden, Jurjen Tel & Carl G. Figdor Cancer immunotherapy can successfully promote long-term anticancer immune responses, although there is still only a limited number of patients who benefit from such treatment, and it can sometimes have severe treatment-associated adverse events. Compared with systemic immunomodulation, local immunomodulation may enable more effective treatment at
Source: Nature Reviews Immunology - Category: Allergy & Immunology Authors: Tags: Perspectives Source Type: research